ELOVL6-IN-2 is a potent and selective small molecule inhibitor of ELOVL6, suitable for oral administration. It is a valuable research tool for investigating fatty acid metabolism in contexts such as metabolic disorders, non-alcoholic fatty liver disease (NAFLD), and cancer, with utility in both in vitro and in vivo studies.